Embryo Report
Advanced genetic screen for your embryos. Prevent your child from inheriting a predisposition to a condition that runs in your family.
Couple Report
Our preconception test measures your future child's genetic predisposition to disease. Mitigate your risk.
For Patients
Comprehensive embryo screening in one test
Whole genome screening enables multiple embryo screening tests from a single biopsy.
PGT-WGS
Whole Genome Screening
Comprehensive embryo screening
PGT-A
Aneuploidy Screening
Screen embryos for chromosomal aneuploidy — extra or missing chromosomes — the leading cause of failed implantation and miscarriage. Includes conditions missed by standard PGT-A platforms like triploidy, molar embryos, and small subtle changes in the chromsomes (microdeletions/microduplications).
Single Gene Disorders
Monogenic Disease Panels
- 200+ neurodevelopmental disorders
- 1000+ birth defects & pediatric conditions
- 90+ cancer predisposition syndromes
PGT-P
Genetic Risk Scores
Evaluate each embryo's genetic predisposition to complex conditions like heart disease, breast cancer, diabetes, and schizophrenia.
Screening for familial conditions
PGT-M
Monogenic Conditions
Screen for a known single-gene condition in your family, like a BRCA mutation, without probes or custom test development.
Learn morePGT-SR
Structural Rearrangements
Identify embryos with balanced or unbalanced translocation, inversion, or other structural rearrangements that could lead to pregnancy loss or genetic conditions.
Learn moreAdditional insights
Origin of Aneuploidy
Determine whether aneuploidy originated from the egg or sperm, providing additional information for your family planning.
Learn moreWhy Orchid?
Orchid uses the same standard 5-6 cell trophectoderm biopsy that other preimplantation genetic tests use — but reads over 99% of an embryo's genome, compared to less than 1% with traditional methods. That means PGT-A, PGT-M, gene panel screening, polygenic risk scores, and more are all included from a single test, with no additional biopsies or coordination required.
Traditional PGT-M requires custom probe design for each familial condition — a process that can take months. Because Orchid's whole genome sequencing reads the full genome rather than targeted regions, no probe design is needed, which means faster test setup and case acceptance. And with 100x more data than traditional PGT, Orchid can detect conditions that other tests miss, including microdeletions, microduplications, triploidy, and molar embryos.
Learn more about how it worksTake the first step
See what the most advanced embryo screening can tell you about your embryos.
Have healthy babies.
Have healthy babies.
© 2026 Orchid